By Manish Mathuria, chief technology officer and co-founder, Infostretch.
The truism that “prevention is better than cure” is especially true in software, where a defect can have serious, sometimes life-threatening, consequences. Digital health presents a unique set of challenges and opportunities for those operating in this competitive and demanding market. The pressure to innovate and advance is immense, but so are concerns about safety, functionality, cost and privacy, to name a few.
When clinical insights combine with IT brilliance, the results can lead to fascinating health innovations. Radical new approaches, such as wearables and mobile devices which monitor, analyze and diagnose conditions, bring special meaning to the importance of error prevention versus recovery.
Lightning-fast technological innovation, fierce competition and stringent regulation combine to bring special challenges to a tester. The implications of software failure are severe. Another adage, “evolve or die,” springs to mind. The traditional testing function is what needs to evolve in this sector perhaps more than any other.
The quality assurance approach to testing must now make way for quality engineering, a new way of tackling quality control which focuses on improving the inherent design of the product throughout the software development life cycle. Why? Because traditional testing, performed at the end of the SDLC is out of its depth in the new era of digital transformation.